Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Drosophila virilis Lateral signaling target protein 2 homolog (GJ23073), partial CSB-YP026476DMP
CSB-EP026476DMP
CSB-BP026476DMP
CSB-MP026476DMP
CSB-EP026476DMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila virilis Kinetochore protein Spc25 (Spc25) CSB-YP022513DMP
CSB-EP022513DMP
CSB-BP022513DMP
CSB-MP022513DMP
CSB-EP022513DMP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Ubiquitin-fold modifier-conjugating enzyme 1 (GK10642) CSB-YP025558DMQ
CSB-EP025558DMQ
CSB-BP025558DMQ
CSB-MP025558DMQ
CSB-EP025558DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Eukaryotic translation initiation factor 3 subunit I (Trip1) CSB-YP007538DMQ
CSB-EP007538DMQ
CSB-BP007538DMQ
CSB-MP007538DMQ
CSB-EP007538DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Pescadillo homolog (GK25349), partial CSB-YP017791DMQ
CSB-EP017791DMQ
CSB-BP017791DMQ
CSB-MP017791DMQ
CSB-EP017791DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila willistoni Lysine-specific demethylase NO66 (GK15670), partial CSB-YP003168DMQ
CSB-EP003168DMQ
CSB-BP003168DMQ
CSB-MP003168DMQ
CSB-EP003168DMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Pescadillo homolog (GE10391), partial CSB-YP017791DMR
CSB-EP017791DMR
CSB-BP017791DMR
CSB-MP017791DMR
CSB-EP017791DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba KRR1 small subunit processome component homolog (dbe) CSB-YP012502DMR
CSB-EP012502DMR
CSB-BP012502DMR
CSB-MP012502DMR
CSB-EP012502DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Eukaryotic translation initiation factor 3 subunit L (GE20146), partial CSB-YP007541DMR
CSB-EP007541DMR
CSB-BP007541DMR
CSB-MP007541DMR
CSB-EP007541DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila yakuba Nuclear cap-binding protein subunit 2 (Cbp20) CSB-YP015521DMR
CSB-EP015521DMR
CSB-BP015521DMR
CSB-MP015521DMR
CSB-EP015521DMR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila simulans Zinc finger CCCH-type with G patch domain-containing protein (GD23643), partial CSB-YP026480DMJ
CSB-EP026480DMJ
CSB-BP026480DMJ
CSB-MP026480DMJ
CSB-EP026480DMJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila simulans Protein arginine N-methyltransferase 7 (Art7), partial CSB-YP018736DMJ
CSB-EP018736DMJ
CSB-BP018736DMJ
CSB-MP018736DMJ
CSB-EP018736DMJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila simulans Eukaryotic translation initiation factor 3 subunit A (eIF3-S10), partial CSB-YP007543DMJ
CSB-EP007543DMJ
CSB-BP007543DMJ
CSB-MP007543DMJ
CSB-EP007543DMJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila simulans Enolase-phosphatase E1 (GD19634) CSB-YP007674DMJ
CSB-EP007674DMJ
CSB-BP007674DMJ
CSB-MP007674DMJ
CSB-EP007674DMJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylobacterium zucineum Translation initiation factor IF-3 (infC) CSB-YP015166EUP
CSB-EP015166EUP
CSB-BP015166EUP
CSB-MP015166EUP
CSB-EP015166EUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylobacterium zucineum GMP synthase [glutamine-hydrolyzing] (guaA), partial CSB-YP009582EUP
CSB-EP009582EUP
CSB-BP009582EUP
CSB-MP009582EUP
CSB-EP009582EUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylobacterium zucineum Porphobilinogen deaminase (hemC) CSB-YP010524EUP
CSB-EP010524EUP
CSB-BP010524EUP
CSB-MP010524EUP
CSB-EP010524EUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylobacterium zucineum Translation initiation factor IF-2 (infB), partial CSB-YP015164EUP
CSB-EP015164EUP
CSB-BP015164EUP
CSB-MP015164EUP
CSB-EP015164EUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phenylobacterium zucineum Urocanate hydratase (hutU), partial CSB-YP025677EUP
CSB-EP025677EUP
CSB-BP025677EUP
CSB-MP025677EUP
CSB-EP025677EUP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria gonorrhoeae Thymidylate kinase (tmk) CSB-YP007226NGB
CSB-EP007226NGB
CSB-BP007226NGB
CSB-MP007226NGB
CSB-EP007226NGB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>